Correlation Study of Vascular Parameters in Hypertensive Men With Erectile Dysfunction
NCT ID: NCT01084187
Last Updated: 2011-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
100 participants
INTERVENTIONAL
2010-01-31
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice
NCT01106118
Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction and Hypertension
NCT00668005
Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia
NCT00668109
Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome
NCT00738400
Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study
NCT01348880
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
vardenafil on demand
four sexual attempts with 20 mg vardenafil during next four weeks
Vardenafil
vardenafil 20 mg on demand or vardenafil daily or placebo
placebo
placebo of vardenafil during four weeks
Vardenafil
vardenafil 20 mg on demand or vardenafil daily or placebo
daily vardenafil
10 mg of vardenafil each day during four weeks
Vardenafil
vardenafil 20 mg on demand or vardenafil daily or placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vardenafil
vardenafil 20 mg on demand or vardenafil daily or placebo
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
50 Years
70 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitario Pedro Ernesto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hospital Universitário Pedro Ernesto
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mario F Neves, MD, PhD.
Role: STUDY_CHAIR
Hospital Universitario Pedro Ernesto
Valter Javaroni, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
State University of Rio de Janeiro
Wille Oigman, MD, PhD
Role: STUDY_DIRECTOR
State University of Rio de Janeiro
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitário Pedro Ernesto
Rio de Janeiro, Rio de Janeiro, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EDAH2010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.